ReviewThrombosis research2023
Breaking down tumor thrombus: Current strategies for medical management.
Review in Thrombosis research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.
- Anticoagulant outcomes in managing tumor thrombus: a systematic review.Frontiers in oncology · 2026Pooled it
- Surgical, endovascular, and systemic management of renal cell carcinoma with intravascular recurrence.Urology case reports · 2026Article
- A thoracic SMARCA4-deficient undifferentiated tumor: A case report.Oncology letters · 2026Article
- Case - Caval thrombectomy for metastatic breast cancer.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2026Article
- Review
- Photon-counting detector CT with iodine quantification: improved distinction between bland and neoplastic portal vein thrombosis.European radiology · 2026Article
- Recurrent Acute Limb Ischaemia due to Malignant Thromboembolism Involving Bilateral Lower Limbs Simultaneously.Cancer reports (Hoboken, N.J.) · 2026Article
- The Impact of Anticoagulation in Patients With Isolated Cancer-Associated Splanchnic Vein Thrombosis: A Dual-Center Cohort Study.American journal of hematology · 2026Article
- Low Survival Rates for Pediatric Patients with Tumor Thrombus in Sarcoma.Journal of clinical medicine · 2026Article
- Commentary: Anticoagulant outcomes in managing tumor thrombus: a systematic review.Frontiers in oncology · 2026Article
- Primary adrenal angiosarcoma: a rare case presentation.Journal of surgical case reports · 2025Article
- Reviewing the Current State of Renal Cell Carcinoma with a Tumor Thrombus: Epidemiology, Pathophysiology, Metastasis, and Systemic Therapy.Current urology reports · 2025Review
- Is Preoperative Anticoagulation in Nephrectomy with Caval Thrombectomy Necessary? A Multicenter Retrospective Cohort Study.European urology open science · 2025Article
- Article
- An interpretable machine learning model for predicting early liver metastasis after pancreatic cancer surgery.BMC cancer · 2025Article
- Inferior Vena Cava Tumor Thrombus in the Emergency Department: A Case Report.Clinical practice and cases in emergency medicine · 2025Article
- Large tumor thrombus extending into the right atrium through the inferior vena cava due to hepatocellular carcinoma: A case report.Radiology case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 2 countries.
Funding
Abstract
Tumor thrombus, the intravascular extension of tumor into adjacent blood vessels, is frequently encountered in patients with renal cell carcinoma and hepatocellular carcinoma, and often involves the abdominal vasculature including the renal vein, portal vein, and the inferior vena cava. While a bland thrombus is composed of platelets and fibrin, in contrast, a tumor thrombus refers to an organized collection of tumor cells. Though oftentimes detected incidentally on imaging, tumor thrombus may have significant clinical implications and can be challenging to differentiate from bland thrombus. Additionally, the optimal management of tumor thrombus, including the use of anticoagulation, remains poorly described. This review summarizes common causes of tumor thrombus, as well as its impact on staging, prognosis, and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.